Pneumonia News and Research

Latest Pneumonia News and Research

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

"Measles is making a rapid comeback in African, Asian and even some European countries despite being easily avoided through vaccination, the World Health Organization said Friday as countries pledged to sharply cut infections and deaths worldwide by 2015," the Associated Press reports (Jordans, 5/22). On the final day of the 63rd Annual World Health Assembly, the assembly endorsed a series of interim targets towards the global eradication of measles, VOA News reports.

25 May 2010

Delegates at the World Health Assembly adopt resolutions on variety of global health issues

The 63rd World Health Assembly, which brought together Health Ministers and senior health officials from the World Health Organization's Member States, concluded business and closed Friday evening.

24 May 2010

WHA passes a new resolution to combat childhood pneumonia

For the first time ever, the World Health Assembly passed a resolution today focused on the prevention and treatment of pneumonia, the world's leading killer of children.

24 May 2010

Genentech to present new data for targeted cancer medicines at 46th ASCO

Genentech, Inc., a wholly owned member of the Roche Group, today announced that it will present new data for its targeted cancer medicines and the way they may be used in several different cancer types at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). Approximately 400 abstracts featuring Genentech and Roche's cancer medicines and investigational agents across 30 cancer types will be presented during the meeting that is taking place June 4 to 8, 2010 in Chicago.

21 May 2010

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

British Columbia is leading the way in vaccinations to protect children from serious disease. The province is the first in Canada to include Prevnar 13, the vaccine that provides the broadest coverage available against Streptococcus pneumoniae that may cause invasive pneumococcal disease, in the routine child immunization program.

21 May 2010

World Health Assembly news

Media outlets continue to track news emerging from the 63rd annual World Health Assembly (WHA) in Geneva.

20 May 2010

New study shows preoperative statin therapy protects patients undergoing elective AAA repair

Preoperative statin therapy has a protective effect on patients undergoing elective abdominal aortic aneurysm repair that reduces risk and subsequent total hospital costs according to a new study from researchers at the East Carolina Heart Institute in Greenville, North Carolina.

20 May 2010

FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis

Allergan, Inc. today announced that the United States Food and Drug Administration has approved ZYMAXID (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms; Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumonia.

20 May 2010

Vaccinations recommended for adults

Yearly vaccinations aren't just for kids any more. You probably heard a lot about a seasonal or H1N1 flu shot last fall, but you should know that a battery of other adult vaccinations might also become part of your health care routine. Pneumonia and shingles vaccines are preventive-care essentials for older adults, and meningitis and tetanus shots are now college rites of passage. Even the vaccines of childhood—measles, mumps and rubella, and whooping cough—are recommended for adults who missed out in their younger years.

19 May 2010

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

Human stem cells administered intravenously can restore alveolar epithelial tissue to a normal function in a novel ex vivo perfused human lung after E. coli endotoxin-induced acute lung injury, according to research from the University of California San Francisco.

18 May 2010

High school student studies effects of repeated x-rays in HMV children admitted for pneumonia

You expect to find leading experts in the fields of pulmonary, critical care and sleep medicine presenting their research at the annual ATS International Conference-physicians and professors, basic scientists, fellows and post-docs, certainly. High school students? Not so much.

18 May 2010

ICU-acquired infection rates are not indication of patients' mortality risk: Researchers

ICU-acquired infection rates are not an indication of patients' mortality risk, according to researchers the University of Pennsylvania, undermining a central tenet of many pay-for-performance initiatives.

18 May 2010

KaloBios Pharmaceuticals' KB001 promising in prevention of serious lung infection

The data from the initial clinical studies with KB001, a novel antibody fragment against PcrV on Pseudomonas aeruginosa (Pa) bioengineered by KaloBios Pharmaceuticals, Inc. and partnered with sanofi pasteur, demonstrated promising therapeutic activity in the prevention of serious lung infection in mechanically ventilated patients colonized with the bacterium and in limiting potentially damaging inflammation in patients with cystic fibrosis, where Pa plays an important role in the disease.

18 May 2010

Hemispherx Biopharma to conduct study of Ampligen antiviral in China

As part of its expanding international program Hemispherx Biopharma, Inc., announced an agreement with Fountain Medical Development Ltd., a leading Chinese clinical research organization (CRO) to prepare, file and gain approval from the authorities in China to conduct a study of Ampligen, an investigational therapeutic.

17 May 2010

Indigenous Australians at higher risk of diseases: studies

Central Australia ranks first in incidences of pneumonia among children with alarming figures like 78.4 cases per 1,000 children annually. This is much higher than even South Africa, Uruguay, Gambia, Fiji or Pakistan.

16 May 2010

Mild-mannered organelles can detect virus invasion signals: Researchers

Within cells, an ancient antiviral duo can deliver a one-two knockout to thwart invading viruses, report researchers who have just unmasked the cellular sidekick that throws the first punch. The findings mean scientists must rethink the design of antiviral immunity and how the body fends off viruses of all types, including influenza and HIV.

14 May 2010

AlphaRx continues to develop Indaflex for the Chinese market

AlphaRx, Inc., has been advised by Cypress Biosciences, its development partner for Indaflex, that Cypress is not funding development of Indaflex. Notwithstanding to the termination of all Indaflex activity in the U.S.A., AlphaRx continues to develop Indaflex for the Chinese market.

13 May 2010

Two-thirds of child deaths in 2008 due to infectious diseases, report finds

Pneumonia, diarrhea, malaria and other infectious diseases accounted for two-thirds of the 8.8 million deaths in 2008 among children under age 5 around the world, according to a Lancet study published on Wednesday, HealthDay News/Bloomberg BusinessWeek reports. The highest numbers of childhood deaths were in Africa (4.2 million) and Southeast Asia (2.39 million), according to the news service (5/11).

13 May 2010

FDA approves Sagent's bacitracin for pneumonia and empyema

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced FDA approval of bacitracin for injection, USP (bacitracin), an anti-infective product used to treat pneumonia and empyema. Bacitracin will be offered in a 50,000 MU, AP-rated, preservative-free, latex-free, single-dose vial packaged both individually and in packages of ten.

13 May 2010

Preventable infectious diseases cause two-thirds of child deaths: The Lancet

Preventable infectious diseases cause two-thirds of child deaths, according to a new study published today by The Lancet. Experts from the World Health Organization and UNICEF's Child Health Epidemiology Reference Group assessed data from 193 countries to produce estimates by country, region and the world.

12 May 2010

Pneumonia News and Research

Latest Pneumonia News and Research

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

Delegates at the World Health Assembly adopt resolutions on variety of global health issues

WHA passes a new resolution to combat childhood pneumonia

Genentech to present new data for targeted cancer medicines at 46th ASCO

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

World Health Assembly news

New study shows preoperative statin therapy protects patients undergoing elective AAA repair

FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis

Vaccinations recommended for adults

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

High school student studies effects of repeated x-rays in HMV children admitted for pneumonia

ICU-acquired infection rates are not indication of patients' mortality risk: Researchers

KaloBios Pharmaceuticals' KB001 promising in prevention of serious lung infection

Hemispherx Biopharma to conduct study of Ampligen antiviral in China

Indigenous Australians at higher risk of diseases: studies

Mild-mannered organelles can detect virus invasion signals: Researchers

AlphaRx continues to develop Indaflex for the Chinese market

Two-thirds of child deaths in 2008 due to infectious diseases, report finds

FDA approves Sagent's bacitracin for pneumonia and empyema

Preventable infectious diseases cause two-thirds of child deaths: The Lancet

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Pneumonia News and Research

Latest Pneumonia News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in